Alzheimer's Disease: Characterization of the Brain Sites of the Initial Tau Cytoskeletal Pathology Will Improve the Success of Novel Immunological Anti-Tau Treatment Approaches.

Rüb U, Stratmann K, Heinsen H, Seidel K, Bouzrou M, Korf H-W

J Alzheimers Dis. 2017; 57(3):683-696. PMID: 28269779. Abstract